Skip to main content
. 2015 Jun 9;39(6):1010–1018. doi: 10.1038/ijo.2015.19

Table 3. Percentage increase (95% CI) of each adiposopathic marker for the selected life course model (n=1280).

  Age and sex only +Smoking status +Childhood SEP +Adulthood SEP Full model
Accumulation model, relaxed a
 Adiponectin (years)          
  15 2.2 (−10.3, 16.4) 0.7 (−11.6, 14.7) 2.2 (−10.2, 16.4) 2.3 (−10.3, 16.5) 1.1 (−11.2, 15.2)
  36 −6.3 (−13.9, 2.0) −4.7 (−12.7, 4.0) −6.0 (−13.7, 2.3) −6.6 (−14.3, 1.8) −4.6 (−12.7, 4.2)
  63 −24.3 (−30.4, −17.7) −26.1 (−32.2, −19.4) −23.8 (−30.0, −17.2) −24.2 (−30.3, −17.6) −25.8 (−32.0, −19.1)
           
 Leptin (years)
  15 15.4 (1.5, 31.2) 17.8 (3.3, 34.4) 15.4 (1.5, 31.2) 17.0 (2.9, 33.1) 19.3 (4.6, 36.0)
  36 26.6 (16.4, 37.6) 23.1 (12.6, 34.4) 25.8 (15.7, 36.8) 26.0 (15.8, 37.1) 21.7 (11.3, 33.0)
  63 135.9 (117.2, 156.2) 135.0 (115.4, 156.4) 133.4 (114.8, 153.6) 135.6 (117.0, 155.9) 132.6 (113.1, 153.9)
           
 CRP (years)
  15 10.1 (−7.5, 31.0) 10.3 (−7.7, 31.8) 10.2 (−7.4, 31.1) 12.6 (−5.4, 33.9) 11.9 (−6.3, 33.7)
  36 14.4 (2.1, 28.1) 13.9 (1.0, 28.4) 13.1 (0.9, 26.6) 13.9 (1.7, 27.7) 13.1 (0.3, 27.6)
  63 37.0 (22.5, 53.1) 39.1 (23.6, 56.5) 34.3 (20.1, 50.3) 35.5 (21.2, 51.4) 36.1 (20.9, 53.3)
           
 Interleukin-6 (years)b
  15 16.4 (1.5, 33.6) 19.1 (3.7, 36.8) 16.5 (1.6, 33.7) 18.3 (3.1, 35.7) 20.9 (5.3, 38.9)
  36 11.1 (1.6, 21.5) 8.9 (−0.8, 19.6) 10.1 (0.7, 20.5) 10.6 (1.1, 21.1) 8.5 (−1.2, 19.1)
  63 20.1 (10.0, 31.2) 20.7 (10.1, 32.3) 18.5 (8.4, 29.5) 19.5 (9.4, 30.5) 19.5 (9.0, 31.1)
           
Early old age sensitive period model (60–64 years only)c
 Adiponectin −30.1 (−37.8, −22.3) −32.0 (−39.9, −24.1) −29.5 (−37.3, −21.7) −29.8 (−37.6, −22.0) −29.8 (−37.8, −21.8)
 E-selectin 16.2 (10.2, 22.5) 17.5 (11.1, 24.2) 15.4 (9.4, 21.8) 16.1 (10.0, 22.4) 16.6 (10.1, 23.4)
 Tissue plasminogen activator 34.3 (25.2, 44.0) 31.3 (21.9, 41.3) 33.9 (24.7, 43.7) 34.2 (25.1, 44.0) 30.9 (21.4, 41.1)

Abbreviations: CI, confidence interval; CRP, C-reactive protein; IL-6, interleukin-6; SEP, socioeconomic position.

a

Overweight compared with non-overweight at 15, 36 or 60–64 years, adjusted for overweight status for the other 2 years.

b

The ‘strict' accumulation model was chosen as the best fitting life course model for IL-6, but P-values were similar to the ‘relaxed' accumulation model, so we have shown the latter model here to compare coefficients for overweight at each age with the other inflammatory marker.

c

Overweight compared with non-overweight at age 60–64 years.